We started as a medical marijuana research company in 2017, focused on leveraging backgrounds in machine learning with cannabis testing data to model cannabinoid and terpene profiles for focusing on particular ailments while avoiding or limiting unwanted psychoactive effects.

Our passion for data started leading our research and led us to explore techniques for solventless extraction of cannabinoids and terpenes. we have since explored all types of extraction technologies and resulting concentrated products.

Bivarin has three pending patent applications to support its research with plans to file several additional applications.